company background image
2CB0 logo

Calithera Biosciences DB:2CB0 Stock Report

Last Price

€0.06

Market Cap

€117.2k

7D

0%

1Y

-98.2%

Updated

14 May, 2023

Data

Company Financials

Calithera Biosciences, Inc.

DB:2CB0 Stock Report

Market Cap: €117.2k

2CB0 Stock Overview

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023.

2CB0 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Calithera Biosciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Calithera Biosciences
Historical stock prices
Current Share PriceUS$0.06
52 Week HighUS$4.80
52 Week LowUS$0.036
Beta1.17
1 Month Change0%
3 Month Change0%
1 Year Change-98.19%
3 Year Change-99.95%
5 Year Change-99.93%
Change since IPO-99.96%

Recent News & Updates

Recent updates

Shareholder Returns

2CB0DE BiotechsDE Market
7D0%2.1%1.9%
1Y-98.2%37.0%7.3%

Return vs Industry: 2CB0 underperformed the German Biotechs industry which returned -23.1% over the past year.

Return vs Market: 2CB0 underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is 2CB0's price volatile compared to industry and market?
2CB0 volatility
2CB0 Average Weekly Movementn/a
Biotechs Industry Average Movement5.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 2CB0's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine 2CB0's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20109Susan Molineauxhttps://www.calithera.com

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Calithera Biosciences, Inc. Fundamentals Summary

How do Calithera Biosciences's earnings and revenue compare to its market cap?
2CB0 fundamental statistics
Market cap€117.18k
Earnings (TTM)-€19.62m
Revenue (TTM)n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2CB0 income statement (TTM)
RevenueUS$0
Cost of RevenueUS$28.53m
Gross Profit-US$28.53m
Other Expenses-US$7.24m
Earnings-US$21.29m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-4.37
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did 2CB0 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.